Marvel Biosciences Corp. (TSXV:MRVL)
Canada
· Delayed Price · Currency is CAD 0.1600
0.00 (0.00%)
Jul 4, 2025, 3:26 PM EDT
Marvel Biosciences Market Cap
Marvel Biosciences has a market cap or net worth of CAD 8.47 million as of July 3, 2025. Its market cap has increased by 93.59% in one year.
Market Cap
8.47M
Enterprise Value
9.79M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.16
Market Cap Chart
Since July 13, 2021, Marvel Biosciences's market cap has decreased from 12.71M to 8.47M, a decrease of -33.33%. That is a compound annual growth rate of -9.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2025 | 8.47M | 11.28% |
| Dec 31, 2024 | 7.61M | 139.21% |
| Dec 29, 2023 | 3.18M | -36.00% |
| Dec 30, 2022 | 4.97M | -43.47% |
| Dec 30, 2021 | 8.80M | -30.77% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sienna Senior Living | 1.72B |
| Green Thumb Industries | 1.69B |
| dentalcorp Holdings | 1.64B |
| Extendicare | 1.15B |
| WELL Health Technologies | 1.07B |
| Cronos Group | 1.06B |
| Trulieve Cannabis | 1.01B |
| Curaleaf Holdings | 856.10M |